コンテンツへスキップ
Merck

Protocol to generate cardiac pericytes from human induced pluripotent stem cells.

STAR protocols (2023-04-29)
Mengcheng Shen, Shane Rui Zhao, Yaser Khokhar, Li Li, Yang Zhou, Chun Liu, Joseph C Wu
要旨

Cardiac pericytes are a critical yet enigmatic cell type within the coronary microvasculature. Since primary human cardiac pericytes are not readily accessible, we present a protocol to generate them from human induced pluripotent stem cells (hiPSCs). Our protocol involves several steps, including the generation of intermediate cell types such as mid-primitive streak, lateral plate mesoderm, splanchnic mesoderm, septum transversum, and epicardium, before deriving cardiac pericytes. With hiPSC-derived cardiac pericytes, researchers can decipher the mechanisms underlying coronary microvascular dysfunction. For complete details on the use and execution of this protocol, please refer to Shen et al.1.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
抗アクチン、α-平滑筋抗体、マウスモノクローナル, clone 1A4, purified from hybridoma cell culture
Sigma-Aldrich
抗硫酸コンドロイチンプロテオグリカン抗体、クローン9.2.27, clone 9.2.27, Chemicon®, from mouse
Sigma-Aldrich
モノクロナール抗カルポニン マウス宿主抗体, clone hCP, ascites fluid